ClariVest Asset Management’s BioTelemetry, Inc. BEAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-2,700
Closed -$110K 757
2019
Q3
$110K Sell
2,700
-31,042
-92% -$1.34M ﹤0.01% 500
2019
Q2
$1.63M Sell
33,742
-20,165
-37% -$1.06M 0.04% 268
2019
Q1
$3.38M Sell
53,907
-3,029
-5% -$208K 0.07% 233
2018
Q4
$3.4M Buy
56,936
+36,336
+176% +$2.18M 0.07% 218
2018
Q3
$1.33M Sell
20,600
-1,400
-6% -$78.1K 0.02% 378
2018
Q2
$990K Buy
22,000
+200
+0.9% +$7.97K 0.02% 445
2018
Q1
$677K Buy
21,800
+500
+2% +$16.4K 0.01% 471
2017
Q4
$637K Hold
21,300
0.01% 466
2017
Q3
$703K Sell
21,300
-48,822
-70% -$1.69M 0.02% 363
2017
Q2
$2.35M Sell
70,122
-119
-0.2% -$3.55K 0.06% 267
2017
Q1
$2.03M Buy
70,241
+400
+0.6% +$9.91K 0.05% 274
2016
Q4
$1.56M Sell
69,841
-11,527
-14% -$225K 0.04% 287
2016
Q3
$1.51M Buy
+81,368
New +$1.53M 0.04% 248

Other funds holding BEAT

ClariVest Asset Management's BEAT Position: Q4 2019 in Review

ClariVest Asset Management sold out of BioTelemetry, Inc. (BEAT) in Q4 2019, closing a stake of 2,700 shares — an estimated $110K sold.

ClariVest Asset Management first reported a position in BEAT in Q3 2016 and held it in 13 quarters. The position peaked at $3.4M in Q4 2018. 219 funds tracked by Wall St. Rank hold BEAT as of Q4 2019.

  • ClariVest Asset Management reported no remaining BioTelemetry, Inc. position as of Q4 2019 after selling out during the quarter.
  • ClariVest Asset Management sold 2,700 BioTelemetry, Inc. shares in Q4 2019, an estimated $110K.
  • ClariVest Asset Management first reported a position in BioTelemetry, Inc. in Q3 2016 and held it in 13 quarters.
  • ClariVest Asset Management's BioTelemetry, Inc. position peaked at $3.4M in Q4 2018.
  • 219 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2019.

Based on ClariVest Asset Management's 13F filing for Q4 2019, filed 12 Feb 2020.